Breaking News
April 22, 2019 - Improving ACA’s Insurance Coverage Provisions will lead to better care for patients
April 22, 2019 - Study identifies possible therapeutic effects of curcumin on stomach cancer
April 22, 2019 - Hyaline fibromatosis syndrome – Genetics Home Reference
April 22, 2019 - Scientists use CRISPR for possible ‘bubble boy’ therapy
April 22, 2019 - Hematologist (and a mom, singer, actress and much more) stands up for diversity
April 22, 2019 - Novel AI voice tool can help diagnose PTSD
April 22, 2019 - Overlooked part of cell’s internal machinery may hold key to treating acute myeloid leukemia
April 22, 2019 - MIT scientists reverse some behavioral symptoms of rare neurodevelopmental disorder
April 22, 2019 - Scientists find new therapy target for drug-induced liver failure
April 22, 2019 - Opioid dose variability could lead to increased risk of overdose, study suggests
April 22, 2019 - Newly developed model predicts salmonella outbreaks several months in advance
April 22, 2019 - Deep-learning model better predicts survival outcomes for lung cancer
April 22, 2019 - One in Three U.S. Adults Aged 35 to 44 May Have Drinking Problem
April 22, 2019 - Why the measles virus is so contagious
April 22, 2019 - Magnet ‘Zap’ to the Brain Might Jumpstart Aging Memory
April 22, 2019 - Immune response to gut microbes may be early indicator of type 1 diabetes
April 22, 2019 - Destination Limbo: Health Suffers Among Asylum Seekers In Crowded Border Shelter
April 22, 2019 - Research shows how dopamine contributes to sex differences in worms
April 22, 2019 - Marijuana users weigh less compared to non-users
April 22, 2019 - Research uncovers critical RNA processing aberrations in ALS and FTD
April 22, 2019 - Many cancer patients use marijuana and prescription opioids, study reveals
April 22, 2019 - Frailty may up fracture risk in patients with type 2 diabetes
April 22, 2019 - Study provides new insight into how obesity, insulin resistance can affect cognition
April 22, 2019 - Study seeks to better understand the genetic causes for hypospadias
April 22, 2019 - FDA grants approval of first generic naloxone nasal spray to treat opioid overdose
April 22, 2019 - FDA authorizes marketing of first medical device to treat ADHD
April 22, 2019 - Vanderbilt researchers to develop and test ‘safe harbor’ standards of care
April 22, 2019 - You’re probably brushing your teeth wrong – here are four tips for better dental health
April 22, 2019 - Pharmacy closures contribute to medication non-adherence among heart patients
April 22, 2019 - Using Edge AI technology to observe behavior of cattle
April 22, 2019 - Bacteria play a role in the development of stomach ulcers in pigs
April 22, 2019 - Hand Hygiene Compliance Poor in Task Transitions
April 22, 2019 - smoking could harm your baby
April 22, 2019 - Scientists identify rare, paradoxical response to antiretroviral therapy
April 21, 2019 - More TV, Tablets, More Attention Issues at Age 5
April 21, 2019 - Drug reduces risk of kidney failure in people with diabetes, study finds
April 21, 2019 - New research identifies novel link between antibiotic resistance and climate change
April 21, 2019 - Simple intervention can provide lasting protection for teens against junk food marketing
April 21, 2019 - The protein p38-gamma identified as a new therapeutic target in liver cancer
April 21, 2019 - Novel system enables researchers to study bacteria within mini-tissues in a dish
April 21, 2019 - Discovery of oral cancer biomarkers could save thousands of lives
April 21, 2019 - Geneva Exhibition committee gives gold medals to two medications developed by Kazan
April 21, 2019 - Scientists aim to minimize or eliminate hair loss during cancer treatment
April 21, 2019 - WiFi interacts with signaling pathways in the human brain
April 21, 2019 - Stroke Hospitalizations Down in Black, White Medicare Enrollees
April 21, 2019 - First common risk genes discovered for autism
April 21, 2019 - Researchers map auditory sensory system of the mouse brain
April 21, 2019 - Scientists Bring Pig’s Brain, Dead 4 Hours, Back to ‘Cellular Activity’
April 21, 2019 - Virtual reality a promising tool for reducing fears and phobia in autism
April 21, 2019 - New analysis lists out opportunities for U.S. medical schools to advance population health
April 21, 2019 - More sleep may help teens with ADHD focus and organize
April 21, 2019 - Breakthrough antibody treatment suppresses HIV without antivirals
April 21, 2019 - AveXis Data Reinforce Effectiveness of Zolgensma in Treating Spinal Muscular Atrophy (SMA) Type 1
April 21, 2019 - Is your hand pain arthritis, carpal tunnel or something else?
April 21, 2019 - Measles outbreaks may become more frequent if vaccination rates continue to decline
April 21, 2019 - Researchers succeed in accelerating process of creating 3D images
April 21, 2019 - Tiny worm mimics key genetic risk for Alzheimer’s
April 21, 2019 - Angry dreams explained by brain waves
April 20, 2019 - Parenteral Antimicrobial Tx at Home Burdens Children’s Caregivers
April 20, 2019 - Diabetes treatment may keep dementia, Alzheimer’s at bay
April 20, 2019 - New bandage-like biosensor collects and analyzes sweat
April 20, 2019 - A comprehensive, centralized database of bovine milk compounds
April 20, 2019 - Two new epigenetic regulators maintain self-renewal of embryonic stem cells
April 20, 2019 - New Evidence That Veggies Beat Steak for Heart Health
April 20, 2019 - Study reveals genes associated with heavy drinking and alcoholism
April 20, 2019 - Texas A&M AgriLife becomes the newest member of NutriRECS international consortium
April 20, 2019 - In most states, insurance won’t cover addiction treatments
April 20, 2019 - Computer-based memory games may be beneficial for individuals with fragile X syndrome
April 20, 2019 - Timing of food intake influences molecular clock in the liver of mice
April 20, 2019 - Precise decoding of breast cancer cells paves way for new treatment option
April 20, 2019 - Scientists use 3D imaging to help model complex processes performed by placenta
April 20, 2019 - MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS
April 20, 2019 - Genetic variants that protect against obesity could aid new weight loss medicines
April 20, 2019 - New technology developed for microscopic imaging in living organisms
April 20, 2019 - when quitting cigarettes, consider using more nicotine, not less
April 20, 2019 - Key proteins can block Listeria without triggering the death of host cells
April 20, 2019 - Researchers create a working model of cerebral tract to study brain function
April 20, 2019 - New study shows that microbes can help break toxic chemical in dust
April 20, 2019 - Scientists use NIR light and injected DNA nanodevice to guide stem cells to injury
April 20, 2019 - Microbial Features ID’d for Pediatric Irritable Bowel Syndrome
The Brain Institute wins $7.04 million grant to investigate ‘neurophilosphy of free will’

The Brain Institute wins $7.04 million grant to investigate ‘neurophilosphy of free will’

image_pdfDownload PDFimage_print

The newly-minted Institute for Interdisciplinary Brain and Behavioral Science (The Brain Institute) at Chapman University, with Dr. Uri Maoz as project leader, is the recipient of a total of $7.04 million to study how the human brain enables conscious control of decisions and actions. The John Templeton Foundation funded $5.34 million; the Fetzer Institute funded $1.55 million; and the remaining $150,000 comes from the Fetzer Memorial Trust. This is Chapman’s largest non-federal research grant to date. With the Chapman Brain Institute serving as the central hub, this grant supports research efforts at 17 universities spanning four continents, including Charité Berlin (Germany), Dartmouth, Duke, Florida State University, Harvard, Indiana University Bloomington, NIH, Monash University (Australia), NYU, Sigtuna (Sweden), Tel Aviv University (Israel), University College London (UK), University of Edinburgh (UK), UCLA and Yale. The project launched at an international conference on the Neuroscience of Free Will that the Brain Institute and Crean College of Health and Behavioral Sciences at Chapman University hosted in mid-March.

“We were pleased to establish Chapman’s Brain Institute and to bring the faculty associated with it to Chapman University last year,” said Daniele Struppa, Ph.D., Chapman University president. “Their approach to research reflects Chapman’s goal of combining research with teaching and involving undergraduate and graduate students at all levels in the process. We are grateful for this grant from the Templeton Foundation and the Fetzer Institute, which recognizes Chapman as a leader in this developing field.”

“This grant aims to create a new field in the study of the brain–the neurophilosphy of free will,” said Uri Maoz, Ph.D., assistant professor of psychology and computational neuroscience at Chapman University. “The extent and scope of human free will has been debated by philosophers for millennia. In recent decades, neuroscientists have joined the discussion, leading to some interesting discoveries. The current project, however, represents a four-year effort forging structured, close collaborations on these questions between eight neuroscientists (including Dr. Aaron Schurger, assistant professor of psychology, the latest faculty recruit to the Brain Institute at Chapman) and nine philosophers from around the world. Hopefully, in 10 years we will look back at the grant and say that’s where it all started,” said Dr. Maoz.

“This large-scale investment, by the John Templeton Foundation and the Fetzer Institute, comes to the Brain Institute even before its official launch next month,” said Amir Raz, Ph.D., Chapman University professor of psychology and brain sciences and director of the Brain Institute. “Work at the Brain Institute addresses fundamental questions of human experience: do we have free will? Are we, in fact, free to do what we wish? What is the role of consciousness in our decisions? We are grateful for the opportunities the combined grant offers as well as the testament it provides to confidence in our work.”

“The Templeton Foundation and Fetzer Institute grant acknowledge that consequential, complex questions find answers only when approached through the lenses of multiple disciplines and their research techniques,” said Janeen Hill, Ph.D., dean of Crean College. “Chapman University and Crean College’s commitment to brain science and its inherent interdisciplinarity is reinforced by the significance of this combined grant.”

Entitled “Consciousness and Free Will: A Joint Neuroscientific-Philosophical Investigation,” the grant aims to advance efforts in the neurophilosphy of free will. For example, researchers at the Brain Institute and their collaborators will use advanced analysis techniques of brain activity and strive to decode decisions and actions before they take place. Or they will use various techniques to compare human brain activity when people make arbitrary decisions (e.g., when asked to randomly raise their left or right hand) and deliberate ones (e.g., when asked to raise their left or right hand to donate to one charity or another).

“This grant, placing Chapman as a leader in neuroscience, reflects our deepening commitment to research and to academic excellence,” said Glenn Pfeiffer, Ph.D., provost of Chapman University. “This announcement comes soon after the recent elevation of Chapman University to Carnegie Classification R2, signifying ‘high research activity.’ We have never been stronger as a research institution than we are right now.”

“In fact,” said Thomas Piechota, Ph.D., PE, vice president of research, “this is an opportune time to partner with Chapman University. The research being conducted by the Brain Institute and throughout Chapman is exciting and innovative. Our faculty are exemplary researchers and the involvement of students of every level – including first-year undergraduates – is a fundamental part of the personalized education that we offer.”

Hosted at the Rinker Health Science campus in Irvine, as well as on the Orange campus, the Brain Institute comprises a network of interdisciplinary researchers who conduct empirical investigations into the cognitive neuroscience of altered planes of consciousness, neuropsychology, volition, formal models of higher brain functions among other fields. Our work draws on clinical populations, healthy volunteers, and innovations in artificial intelligence, machine learning, and big data.

“Questions about consciousness and free will are of enduring interest in both philosophy and the sciences. This project will feature field-leading researchers on these two topics, using rigorous and collaborative methods to advance our understanding of both of them. It is therefore a perfect fit for the John Templeton Foundation, and we are pleased to support Chapman in this initiative,” said John Churchill, director of philosophy and theology programs at the John Templeton Foundation.

“We are drawn to this work because of its cutting-edge exploration of free will, the breadth of the research effort Chapman University has developed, and the scale of this major funding collaboration with Templeton,” said Mohammed Mohammed, Fetzer Institute program director of research, discovery, and development. “We are excited about this venture into the intersection of philosophy and neuroscience.”

Tagged with:

About author

Related Articles